These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1671192)

  • 1. Clinical perspective on celiprolol: cardioprotective potential.
    Frishman WH
    Am Heart J; 1991 Feb; 121(2 Pt 2):724-9. PubMed ID: 1671192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade.
    Frishman WH; Lazar EJ
    Am J Cardiol; 1990 Nov; 66(16):66G-70G. PubMed ID: 1978548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S9-13. PubMed ID: 2481791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central and peripheral hemodynamics of celiprolol.
    Mancia G
    Am Heart J; 1988 Nov; 116(5 Pt 2):1405-11. PubMed ID: 2903651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ; Buckley MM
    Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
    Silke B; Verma SP; Guy S
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):681-7. PubMed ID: 1679661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.
    Heublein B; Modersohn D; Franz N; Panzner B
    Eur Heart J; 1991 May; 12(5):617-23. PubMed ID: 1678705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.
    Kendall MJ; Rajman I
    Drug Saf; 1994 Mar; 10(3):220-32. PubMed ID: 7913813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of celiprolol in hypertension and angina pectoris. Introduction.
    Norris RJ
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1195-6. PubMed ID: 1672600
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
    Klinger D
    Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ
    Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG; Shanks RG; Brogden RN
    Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins.
    Hunninghake DB
    Am Heart J; 1991 Feb; 121(2 Pt 2):696-701. PubMed ID: 1671189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.